Subcutaneous anakinra in the management of refractory MIS-C in France.

"Conflict of interest IK-p received honoraria as speaker or consultant from SOBI, Novartis, LFB, PFIZER, zydus, Cellgene, frezenius Kabi, CHUGAI but not for this work. PD received congress fees from SOBI, Novartis, Abbvie, PFIZER. AB reports consulting fees from Kabi, Roche Chugai, GlaxoSmithKline, AbbVie, Novartis. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."

"The authors declare financial support was received for the research, authorship, and/or publication of this article.This study was supported by the JIR cohort program and by a grant from the Swedish Orphan Biovitrum."